Breaking News Instant updates and real-time market news.

TLGT

Teligent

$7.54

-0.11 (-1.44%)

08:04
10/05/16
10/05
08:04
10/05/16
08:04

Teligent unit receives approval from Health Canada for Lidocaine Ointment USP 5%

Teligent announced that its Estonian subsidiary, Teligent Oundefined, has received approval from Health Canada's Therapeutic Products Directorate for Lidocaine Ointment USP 5%. This is the sixth approval for Teligent Oundefined this calendar year and will be distributed by Teligent's business in Canada. Based on internal estimates, the total addressable market for this product is approximately C$1.3M.

  • 15

    Nov

TLGT Teligent
$7.54

-0.11 (-1.44%)

06/22/16
RAJA
06/22/16
INITIATION
Target $11
RAJA
Strong Buy
Teligent initiated with a Strong Buy at Raymond James
Raymond James analyst Elliot Wilbur initiated Teligent with a Strong Buy and $11 price target. The analyst believes the company is poised for a major growth spurt powered by its TICO product development and selection strategy that has resulted in the assembly of an enriched pipeline of long duration growth assets in high barrier to entry generic markets.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.